Please enable JavaScript
Powered by Benchmark MaSS English, Author at Matribhumi Samachar English - Page 332 of 2610
Wednesday, January 21 2026 | 07:59:19 PM
Home / MaSS English (page 332)

MaSS English

MBody AI ($CHEK) Secures 98% Shareholder Approval to Become Leading Nasdaq Embodied AI Company

Nasdaq-listed AI company gains overwhelming shareholder support for its transformational merger, positioning MBody AI ($CHEK) as a hardware-agnostic embodied intelligence leader ready to scale enterprise automation. Las Vegas, Nevada and Isfiya, Isreal–(Newsfile Corp. – November 17, 2025) – MBody AI Corp. (“MBody AI”) and Check-Cap Ltd. (NASDAQ: CHEK) ($CHEK) (“Check-Cap”) …

Read More »

RIQZ Expands Its AI Vision in Africa

London, United Kingdom–(Newsfile Corp. – November 17, 2025) – RIQZ announced today that it is expanding its focus on the African market, underscoring the company’s long-term commitment to supporting organisations across the continent with scalable and transparent AI-driven decision tools. To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8530/274711_68ecfde084315aa8_001full.jpg …

Read More »

AITX’s RAD Adds Major Sports Venue to Client List

Company Secures 10 SARA Licenses with 10 ROSA Unit Order to Address Persistent Criminal Behavior Detroit, Michigan–(Newsfile Corp. – November 17, 2025) – Artificial Intelligence Technology Solutions, Inc. (OTCID: AITX) (the “Company”), a global leader in AI-driven security and productivity solutions, along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. (RAD), …

Read More »

Phio Pharmaceuticals Announces Upcoming Podium Presentation at the Advanced Therapies USA 2025 Congress

Presenting INTASYL siRNA Drug Technology King of Prussia, Pennsylvania–(Newsfile Corp. – November 17, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that a podium presentation highlighting INTASYL® siRNA Drug Technology …

Read More »

SOL Strategies Selected as Staking Provider for VanEck Solana ETF

Toronto, Ontario–(Newsfile Corp. – November 17, 2025) – SOL Strategies Inc. (CSE: HODL) (NASDAQ: STKE) (“SOL Strategies” or the “Company”), the first publicly traded company to combine a substantial Solana treasury with a revenue-generating validator operating business, today announced its selection as a staking provider for the VanEck Solana ETF …

Read More »

CleanTech Expands Royalty Agreement With Oracle Commodity Holding to Include Newly Acquired Illinois Fluorspar Properties

Vancouver, British Columbia–(Newsfile Corp. – November 17, 2025) – CleanTech Vanadium Mining Corp. (TSXV: CTV) (OTCQB: CTVFF) (“CleanTech” or the “Company“) and Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) (“Oracle Commodity Holding“) announce that U.S. Fluorspar LLC (“USF“), CleanTech’s wholly-owned subsidiary, and Oracle Commodity Holding have entered into a …

Read More »

Crombie REIT Announces November 2025 Monthly Distribution

New Glasgow, Nova Scotia–(Newsfile Corp. – November 17, 2025) – Crombie Real Estate Investment Trust (TSX: CRR.UN) (“Crombie”) today announced a distribution of $0.07500 per Unit for the period from November 1, 2025, to and including November 30, 2025. The distribution will be payable on December 15, 2025, to Unitholders of record …

Read More »

Adaptimmune Announces Changes to Board and Executive Leadership Team

Philadelphia, Pennsylvania and Oxford, United Kingdom–(Newsfile Corp. – November 17, 2025) – Adaptimmune Therapeutics plc (OTC Pink: ADAPY) (“Adaptimmune” or the “Company”) today announced changes to the Company’s Board of Directors (“Board”) and its Executive Leadership team, which are effective from November 14, 2025. Christopher (Chris) Hill, currently Chief Financial …

Read More »